| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 72.831 | 297.637 | 309.276 | 314.549 | 116.738 |
| Total Income - EUR | - | - | - | - | 0 | 82.159 | 298.604 | 309.278 | 314.553 | 116.739 |
| Total Expenses - EUR | - | - | - | - | 86.298 | 160.514 | 311.672 | 332.463 | 349.534 | 105.120 |
| Gross Profit/Loss - EUR | - | - | - | - | -86.298 | -78.356 | -13.068 | -23.186 | -34.982 | 11.619 |
| Net Profit/Loss - EUR | - | - | - | - | -86.298 | -79.074 | -16.004 | -26.318 | -38.188 | 9.306 |
| Employees | - | - | - | - | 2 | 3 | 0 | 5 | 5 | 1 |
Check the financial reports for the company - Wellclinic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 9.725 | 7.729 | 3.960 | 3.027 | 1.128 | 785 |
| Current Assets | - | - | - | - | 4.190 | 13.385 | 20.882 | 17.452 | 24.538 | 12.727 |
| Inventories | - | - | - | - | 2.152 | 2.379 | 962 | 1.559 | 2.074 | 0 |
| Receivables | - | - | - | - | 163 | 7.439 | 13.999 | 13.862 | 17.619 | 12.418 |
| Cash | - | - | - | - | 1.876 | 3.567 | 5.921 | 2.031 | 4.845 | 309 |
| Shareholders Funds | - | - | - | - | -76.605 | -154.226 | -166.412 | -193.247 | -230.849 | -220.253 |
| Social Capital | - | - | - | - | 9.694 | 9.510 | 9.299 | 9.328 | 9.300 | 9.248 |
| Debts | - | - | - | - | 90.520 | 175.340 | 192.668 | 218.519 | 259.358 | 233.806 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Wellclinic S.r.l.